ClinConnect ClinConnect Logo
Search / Trial NCT06626100

A Digital Game on Promoting Family Well-being

Launched by THE UNIVERSITY OF HONG KONG · Oct 1, 2024

Trial Information

Current as of June 26, 2025

Not yet recruiting

Keywords

Gamification Family Well Being

ClinConnect Summary

This clinical trial is studying how digital games can help improve family well-being and promote healthy living. Researchers believe that using games and technology can be an effective way to encourage families to engage in healthier habits together. As part of this study, they will conduct an online survey to learn more about how families currently use games for health promotion, followed by a family-based trial that will involve participating in these games.

To be eligible for this trial, participants need to be Chinese-speaking and have a smartphone. If anyone is under 18, they will need permission from their parents. The trial is open to individuals of all ages, and everyone who meets the criteria is welcome to join. If you decide to participate, you can expect to play games designed to promote healthy living and connect with your family in a fun way. Currently, the trial is not yet recruiting participants, but it aims to gather valuable insights into how games can support families in leading healthier lives.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Chinese-speaking;
  • Parental consent for those under 18;
  • Able to understand and play the game;
  • Has a smartphone.
  • Exclusion Criteria:
  • • Individuals who cannot meet the inclusion criteria.

About The University Of Hong Kong

The University of Hong Kong (HKU) is a leading research institution dedicated to advancing medical knowledge and improving healthcare outcomes through innovative clinical trials. With a commitment to excellence in research and education, HKU collaborates with various stakeholders, including healthcare providers and industry partners, to conduct rigorous and ethically sound clinical studies. The university's diverse expertise and state-of-the-art facilities enable it to explore a wide range of therapeutic areas, contributing to the global pursuit of scientific advancement and the development of novel treatment strategies.

Locations

Hong Kong, , Hong Kong

Patients applied

0 patients applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported